IRIS
HEFFLER, Enrico Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.896
AS - Asia 7.876
EU - Europa 3.155
SA - Sud America 1.669
AF - Africa 415
Continente sconosciuto - Info sul continente non disponibili 265
OC - Oceania 49
AN - Antartide 1
Totale 25.326
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.557
SG - Singapore 4.785
BR - Brasile 1.375
CN - Cina 1.163
IT - Italia 917
VN - Vietnam 769
DE - Germania 448
FI - Finlandia 407
IE - Irlanda 318
NG - Nigeria 263
HK - Hong Kong 262
FR - Francia 214
IN - India 182
CA - Canada 181
GB - Regno Unito 172
NL - Olanda 155
AR - Argentina 115
MX - Messico 98
BD - Bangladesh 95
SE - Svezia 90
RU - Federazione Russa 78
TR - Turchia 75
ID - Indonesia 66
IQ - Iraq 59
ZA - Sudafrica 53
TW - Taiwan 51
EC - Ecuador 49
JP - Giappone 47
ES - Italia 45
KR - Corea 45
BE - Belgio 44
AU - Australia 42
CZ - Repubblica Ceca 41
PK - Pakistan 39
PL - Polonia 37
CO - Colombia 35
MY - Malesia 35
UA - Ucraina 33
VE - Venezuela 31
CH - Svizzera 28
IL - Israele 26
CL - Cile 24
SA - Arabia Saudita 23
AT - Austria 22
JO - Giordania 22
MA - Marocco 22
PY - Paraguay 17
UZ - Uzbekistan 16
DZ - Algeria 15
EG - Egitto 15
RO - Romania 15
AE - Emirati Arabi Uniti 13
NP - Nepal 13
AZ - Azerbaigian 12
KE - Kenya 12
PH - Filippine 12
PT - Portogallo 12
PE - Perù 11
LT - Lituania 10
TN - Tunisia 10
UY - Uruguay 10
AL - Albania 9
CR - Costa Rica 9
IR - Iran 8
JM - Giamaica 8
TH - Thailandia 8
GT - Guatemala 7
KZ - Kazakistan 7
NO - Norvegia 7
SN - Senegal 7
DK - Danimarca 6
ET - Etiopia 6
HR - Croazia 6
TT - Trinidad e Tobago 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
GR - Grecia 5
KG - Kirghizistan 5
LB - Libano 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
OM - Oman 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
DO - Repubblica Dominicana 4
HU - Ungheria 4
LV - Lettonia 4
MD - Moldavia 4
PS - Palestinian Territory 4
SI - Slovenia 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
CI - Costa d'Avorio 3
GM - Gambi 3
HN - Honduras 3
KH - Cambogia 3
PR - Porto Rico 3
SV - El Salvador 3
Totale 25.031
Salva come PNG Salva come JPEG
Città #
Singapore 1.979
Chandler 1.324
Wilmington 1.290
Dallas 836
Ashburn 775
The Dalles 732
San Jose 552
San Mateo 482
Shanghai 457
Ann Arbor 416
Helsinki 402
Dublin 297
New York 295
Milan 275
Ho Chi Minh City 274
Boardman 260
Benin City 259
Princeton 247
Beijing 236
Lawrence 234
Hong Kong 229
Leawood 221
Santa Clara 187
Los Angeles 173
Hanoi 168
São Paulo 127
Fairfield 125
Falkenstein 125
Paris 124
Rome 117
Woodbridge 107
Amsterdam 106
Buffalo 88
Toronto 80
London 68
Seattle 57
Orem 45
Council Bluffs 40
Munich 40
Rio de Janeiro 40
Haiphong 39
Da Nang 38
Belo Horizonte 36
Columbus 36
San Diego 36
Naples 35
Phoenix 34
Redwood City 34
Brussels 32
Mexico City 31
Kocaeli 30
Norwalk 30
Pune 29
Turin 29
Brooklyn 28
Chicago 28
Menlo Park 28
Warsaw 28
Charlotte 25
Boston 24
Curitiba 24
Frankfurt am Main 24
Philadelphia 24
Tokyo 24
Figino 23
Johannesburg 23
Mumbai 23
Newark 23
Brasília 22
Campinas 22
Houston 22
Baghdad 21
Chennai 21
Monmouth Junction 21
Montreal 21
San Francisco 21
Brno 20
Miami 20
Stockholm 20
Atlanta 19
Guayaquil 19
Amman 18
Denver 18
Jakarta 18
Porto Alegre 17
Salvador 17
Falls Church 15
Can Tho 14
Dongguan 14
Genoa 14
Hyderabad 14
Nuremberg 14
Goiânia 13
Guarulhos 13
Ottawa 13
Quito 13
Des Moines 12
Dhaka 12
Florence 12
Hillsboro 12
Totale 15.249
Salva come PNG Salva come JPEG
Nome #
The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology. 762
Multi-strain Symbiotic Preparations as a Novel Adjuvant Approach to Allergic Rhinitis 385
Probiotics as a Novel Adjuvant Approach to Atopic Dermatitis 305
Olfactory impairment in Italian patients with chronic rhinosinusitis with nasal polyps: a patient-centered survey 193
NAPPREB study protocol: A pivotal clinical trial to investigate clinical efficacy and potential response biomarkers to Benralizumab treatment in chronic rhinosinusitis with nasal polyps 164
"Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study". 161
A critical appraisal on AIT in childhood asthma. 155
Research needs in allergy: an EAACI position paper, in collaboration with EFA 150
Multiple Drug Allergy Due to Hypersensitivity to Polyethylene Glycols of Various Molecular Weights 145
Allergy in severe asthma. 135
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 134
Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps 133
Macrogol hypersensitivity reactions during cleansing preparation for colon endoscopy. 133
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. 131
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry 130
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model 126
Italian study on buckwheat allergy: prevalence and clinical features of buckwheat-sensitized patients in Italy 124
A Bloody Mess: An Unusual Case of Diffuse Alveolar Hemorrhage Because of Warfarin Overdose 122
Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey 119
Adherence issues related to sublingual immunotherapy as perceived by allergists. 119
The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition 118
Hypersensitivity to gelatin used as excipient for soft capsules of Ibuprofen 118
An academic allergy unit during COVID-19 pandemic in Italy. 117
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study. 117
Exhaled nitric oxide measurements: correction equation to compare hand-held device to stationary analyzer 116
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study. 115
Acute urticaria presenting in the emergency room of a general hospital 114
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. 113
Nasal nitric oxide concentration in suspected chronic rhinosinusitis 109
Pertinence of requested allergy consultations for suspected food allergy/intolerance. A Junior Members working group of Italian Society of Allergy and Clinical Immunology (SIAIC) multicenter study. 106
The Severe Asthma Network in Italy: Findings and Perspectives 105
Allergy in internet 105
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps 103
Acute asthma management during SARS-CoV2-pandemic 2020 103
Treatable traits in chronic rhinosinusitis with nasal polyps 103
Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis 103
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 102
Incidence of food anaphylaxis in Piemonte region (Italy): data from registry of Center for Severe Allergic Reactions. 101
Level of exhaled nitric oxide during human anaphylaxis 100
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 100
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 99
Allergy to buckwheat: an emerging clinical problem. Clinical and laboratory analysis of 24 consecutive patients 98
Allergen immunotherapy and biologics in respiratory allergy: friends or foes? 97
Breath analysis in patients with end-stage renal disease: effect of haemodialysis 95
Nasal cytology: Methodology with application to clinical practice and research. 95
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 94
Asthma from immune pathogenesis to precision medicine 94
Unexpected visitor: “hidden” food allergens 93
Gene Environment Interactions in Respiratory Diseases – Protocol, Standard Operative Procedures and Questionnaires 92
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma 92
Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy? 91
Exhaled nitric oxide in asthma. 90
Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis 90
Unexplained chronic cough and vitamin B-12 deficiency. 90
Strategies to reduce corticosteroid-related adverse events in asthma 90
Community pharmacist's professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists 90
Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets 89
Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma 89
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice 89
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence" 89
Alpha1-antitrypsin deficiency and asthma 89
Anaphylaxis after eating italian pizza containing buckwheat as the hidden allergen 88
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 88
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 88
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 88
Prevalence of over-/misdiagnosis of asthma in patients referred to an allergy clinic. 87
Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment. 87
Anaphylaxis after a horse bite 87
Extended IgE profile based on an allergen macroarray: a novel tool for precision medicine in allergy diagnosis. 87
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps 87
Microarray Immunodiagnostics for Aeroallergens 86
Eosinophils Target Therapy for Severe Asthma: Critical Points 86
Warning nonrespiratory symptoms in asthma: catastrophic abdominal involvement in a case of Churg-Strauss syndrome 85
The Patient-Centered Decision System as per the 4Ps of Precision Medicine 85
Minimal clinically important difference for asthma endpoints: an expert consensus report 85
New drugs in early-stage clinical trials for allergic rhinitis 84
Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects 84
One year of mepolizumab. Efficacy and safety in real-life in Italy 84
Cross-Country Comparison of Demographic and Clinical Characteristics of Patients Managed in Severe Asthma Services Across UK, USA, Australia, South Korea, and Italy 84
Anisakis hypersensitivity in Italy: prevalence and clinical features: a multicenter study. 83
Nasal nitric oxide in patients with inherited retinal dystrophies. 82
Clinical manifestations, co-sensitizations, and immunoblotting profiles of buckwheat-allergic patients. 82
Interleukin-5 in the Pathophysiology of Severe Asthma 82
EAACI consensus statement for investigation of work-related asthma in non-specialized centres 82
Escaping the trap of allergic rhinitis. 81
Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. 81
Epinephrine autoinjector prescription in food-allergic adults: symptom-based only or allergen-based also? An Italian multi-centre study 81
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 81
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center 80
Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. 80
Validation of the Italian version of the Test of Adherence to Inhalers (TAI) 80
Exhaled nitric oxide as a marker of diseases 80
Impact of asthma on bronchiectasis severity and risk of exacerbations 80
Advancing Precision Medicine in Asthma: Evolution of Treatment Outcomes 79
Bronchodilator response as a marker of poor asthma control 79
Exhaled breath condensate pH and cysteinyl leukotriens in patients with chronic cough secondary to acid gastroesophageal reflux 79
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 79
Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients 79
Determinants of exhaled nitric oxide in chronic rhinosinusitis 78
Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of 'reboot' surgery. 78
Totale 11.165
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.360 0 37 51 298 22 30 52 190 117 110 380 73
2022/20233.681 550 149 348 416 354 295 26 290 657 297 234 65
2023/20242.110 183 242 437 66 114 184 90 136 63 60 176 359
2024/20254.141 128 105 78 106 156 385 229 392 643 925 467 527
2025/202610.551 1.378 623 992 1.086 317 388 2.606 669 554 584 451 903
2026/2027765 758 7 0 0 0 0 0 0 0 0 0 0
Totale 25.326